Condition
Esophagus Squamous Cell Carcinoma
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 2 (3)
Trial Status
Recruiting2
Unknown1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT03712566Active Not Recruiting
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
NCT05865132Phase 2RecruitingPrimary
Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction
NCT04018872Phase 2Recruiting
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
NCT03585530Phase 2UnknownPrimary
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus
Showing all 4 trials